Mary E Ritchey

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Health Insurance

Electronic Health Record

Top Venues

Pharmacoepidemiology and drug safety

Neurology and therapy

Drugs - real world outcomes

Clinical, cosmetic and investigational dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

J Bradley Layton, Mary E Ritchey, Zhongwen Huang, Shailesh Chavan, Hakan Ay, Nizar Souayah, Colin Anderson-Smits
Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study. Neurology and therapy (2023)
Colin Anderson-Smits, Mary E Ritchey, Zhongwen Huang, Shailesh Chavan, Nizar Souayah, Hakan Ay, J Bradley Layton
Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis. Neurology and therapy (2023)
Rishi J Desai, Mufaddal Mahesri, Su Been Lee, Vijay R Varma, Tina Loeffler, Irene Schilcher, Tobias Gerhard, Jodi B Segal, Mary E Ritchey, Daniel B Horton, Seoyoung C Kim, Sebastian G Schneeweiss, Madhav Thambisetty
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study. Brain communications 4 (5) (2022)
Cynthia J Girman, Mary E Ritchey, Vincent Lo Re
Real-world data: Assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products. Pharmacoepidemiology and drug safety 31 (7) (2022)
J Bradley Layton, Joan Forns, Mary Ellen Turner, Colleen Dempsey, Jennifer L Bartsch, Mary S Anthony, Heather E Danysh, Mary E Ritchey, George Demos
Falls and Fractures in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study. Drugs - real world outcomes (2021)
Shaundra Eichstadt, Jean Y Tang, Daniel C Solis, Zurab Siprashvili, M Peter Marinkovich, Nedra Whitehead, Matthew Schu, Fang Fang, Stephen W Erickson, Mary E Ritchey, Max Colao, Kaye Spratt, Amir Shaygan, Mark J Ahn, Kavita Y Sarin
From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). Clinical, cosmetic and investigational dermatology 12 (2019)
Wendy Camelo Castillo, Nicholas Heath, John Kim, Kimberly Yang, Mary E Ritchey, Susan dosReis, Nancy Santanello, Suzanne L West
Engaging stakeholders in pharmacoepidemiology research: Current state and recommendations. Pharmacoepidemiology and drug safety 28 (6) (2019)
Cynthia J Girman, Mary E Ritchey, Wei Zhou, Nancy A Dreyer
Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary. Pharmacoepidemiology and drug safety 28 (4) (2018)